Affiliate Disclosure
This article contains affiliate links. If you purchase through these links, we may earn a commission at no additional cost to you. This does not influence our evaluations or rankings.
Perry Baromedical has manufactured FDA-cleared multiplace hyperbaric chambers since 1941, making it one of the oldest names in clinical HBOT. Their systems are built for high-volume hospital and research settings, with chambers supporting pressures up to 6.0 ATA and capacities up to 16 patients. This guide covers Perry’s product line, pricing, specifications, and how they compare to alternatives.
Table of Contents
Perry Hyperbaric Chambers vs Other Brands
| Feature | Perry | Sechrist | Tekna |
| Build Quality | Heavy-duty steel, seamless welds, precision machining | Acrylic and aluminum mix, durable but surface-prone | Stainless steel and acrylic blend, solid durability |
| Patient Comfort | Clear viewing panels, quiet operation, temperature control | Excellent visibility, higher ambient noise levels | Good comfort, some models lack climate control |
| Safety Systems | Multiple redundant pressure relief valves, NFPA 99 and ASME PVHO-1 compliant | Meets NFPA and ASME standards, fewer redundant systems | Meets major standards, manual controls more common |
| Model Range | Monoplace and multiplace for small clinics to large hospitals | Primarily monoplace, limited multiplace options | Strong multiplace focus, fewer monoplace choices |
| Support | Comprehensive operator training, strong after-sales service | Good training, variable response times | International network, longer parts lead times |
| Price Range | $80K to $500K+ | $70K to $450K | $90K to $550K |
| Best For | High-volume clinics, hospitals, and wellness centers | Smaller clinics prioritizing visibility | Multi-patient facilities, less need for compact units |
Perry’s Position in the Industry
Perry has been designing and manufacturing hyperbaric chambers for decades, building equipment used in wound care centers, hospital systems, and specialty clinics across the United States. Their focus on both monoplace and multiplace units gives facilities flexibility that some competitors lack.
Their market position is built on engineering reputation rather than marketing. Clinicians who run high-volume HBOT programs consistently cite Perry among their preferred equipment brands, a track record that matters when a chamber is expected to run multiple sessions per day for years.
HBOT involves pressurizing 100% oxygen in an enclosed space. That requires engineering precision and proven safety systems. In a high-use clinical setting, equipment reliability is not a premium feature, it is a clinical necessity.
BaricBoost editorial note
Safety Standards and Compliance
Perry chambers meet or exceed the safety standards required in the US and most international markets. Key certifications include:
- ASME PVHO-1 compliance for pressure vessels used for human occupancy
- NFPA 99 requirements for health care facilities
- Built-in electrical and fire safety systems on every model
A 2024 review in the National Library of Medicine confirmed that hyperbaric therapy has a well-established safety profile when delivered by trained personnel following established protocols, with serious adverse events being uncommon when guidelines are followed.1 Perry’s operator training program is designed to meet that standard, covering both procedural protocols and the physiological principles that make those protocols necessary.
FDA-cleared indications for HBOT, including wound healing, radiation injury, and decompression sickness. Hard-shell chambers like Perry’s are required to achieve clinical pressures for most of these indications.
Clinical Applications
Perry chambers are used across the spectrum of FDA-cleared HBOT indications. Common clinical applications in facilities using Perry equipment include:
- Chronic wound healing and diabetic foot ulcers
- Decompression sickness
- Delayed radiation injury to soft tissue and bone
- Necrotizing soft tissue infections
- Compromised surgical grafts and flaps
- Carbon monoxide poisoning
Clinics using Perry units report consistent patient feedback on comfort. For multi-session treatments (most clinical protocols run 20 to 40 sessions), patient comfort directly affects compliance, which affects outcomes.
What HBOT Evidence Supports
Understanding what HBOT is clinically proven to do helps any facility make the case for equipment investment. The evidence base for approved indications is strong. A Cochrane review confirmed that HBOT significantly improves healing rates for chronic wounds and diabetic foot ulcers (RR 1.94 for wound healing, 95% CI 1.39-2.70).2 A separate analysis found a number-needed-to-treat of 7 to prevent one death in severe traumatic brain injury using HBOT.3
For diabetic foot ulcers, HBOT nearly doubles the likelihood of wound healing compared to standard care, with a Cochrane-reviewed relative risk of 1.94. This is the kind of clinical evidence that justifies equipment investment for facilities treating high volumes of wound care patients.
Kranke et al., 2015, Cochrane Database
Beyond approved indications, emerging research is expanding the clinical conversation. HBOT at 2.0 ATA in healthy adults over 64 has produced significant improvements in cognitive function (p=0.0017) and telomere lengthening of over 20% in a prospective trial.4 These applications are not yet FDA-approved but are driving growing clinical interest, and facilities with Perry equipment are positioned to treat patients as indications expand.
Cost Considerations
Perry hyperbaric chamber pricing varies by model and configuration:
- Monoplace units: typically $80,000 to $150,000
- Multiplace units: typically $250,000 to $500,000+
Total cost of ownership includes installation, operator training, annual maintenance, and parts. Facilities evaluating Perry against lower-cost alternatives should factor these ongoing costs into the comparison. A chamber that requires less downtime and repairs over a 10-year lifespan often costs less overall than a cheaper unit that needs frequent servicing.
The US HBOT market was valued at approximately $1 billion in 2025 and is projected to grow at 6.22% annually to $1.72 billion by 2034, according to Precedence Research. Facilities that invest in durable equipment now are positioned for a growing patient base over the next decade. For context on the broader market, see our guide to hyperbaric chamber purchasing considerations.
Buying and Installation
When ordering a Perry chamber, the general process involves an initial needs assessment with their sales team to select the appropriate model, site planning and preparation (electrical requirements, room dimensions, ventilation), delivery and installation by certified technicians, and operator training for all staff who will run the equipment.
Lead times vary by model. Monoplace units are typically available more quickly than custom multiplace configurations. Perry’s installation team coordinates with facilities on the technical requirements, including electrical load, oxygen supply infrastructure, and any construction modifications needed to meet NFPA 99 requirements for the room housing the chamber.
Maintenance and Service
Perry’s service infrastructure is one of its competitive strengths. Regular maintenance for a clinical chamber includes pressure seal inspection, oxygen delivery system checks, electrical safety testing, and emergency system verification. Perry provides scheduled maintenance programs and has trained technicians available in most major US markets.
Parts availability matters enormously for facilities running daily HBOT programs. An unplanned chamber shutdown affects patient scheduling and clinic revenue. Perry’s established parts supply chain reduces the risk of extended downtime compared to some less widely distributed brands.
Is Perry Right for Your Facility?
Perry is a strong choice for:
- Clinics with steady HBOT patient volume running multiple sessions per day
- Hospital-based wound care programs where equipment reliability is critical
- Facilities that value long-term support and parts availability over the lowest upfront price
Perry may not be the best fit if your facility only plans occasional HBOT sessions, in which case rental or a refurbished unit may make more financial sense. For high-volume clinical programs treating patients daily, the investment in a new Perry chamber typically justifies itself through reliability and patient confidence.
Final Thoughts
The Perry hyperbaric chamber is not just medical equipment. It is a long-term investment in reliable HBOT delivery. For facilities committed to offering high-quality therapy, Perry provides the engineering integrity and service infrastructure to match that commitment.
The decision to purchase should weigh the brand’s track record, safety certifications, patient comfort, and long-term support alongside the sticker price. On those criteria, Perry earns its place on any serious buyer’s shortlist.
References
- Mago V. Safety of hyperbaric medicine in clinical scenarios. National Library of Medicine. 2024. PMC10922184
- Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015. DOI: 10.1002/14651858.CD004123.pub4
- Bennett MH, et al. Hyperbaric oxygen therapy for acute coronary syndrome. Cochrane Database Syst Rev. 2012. DOI: 10.1002/14651858.CD004123
- Hachmo Y, et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells. Aging. 2020;12(22):22445-22456. DOI: 10.18632/aging.202188
- Precedence Research. Hyperbaric Oxygen Therapy Market Size 2025-2034. precedenceresearch.com
Medical Disclaimer
The content on BaricBoost.com is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Author
Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.
Why Trust Our Evaluations
Our rankings are based on hands-on testing, published clinical data, and verified manufacturer specifications. We apply the same criteria to every product regardless of affiliate status. Editorial Process · Evaluation Methodology
